Paper55716
Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.
Cochrane AM and 4 others. Lancet, 1976. Cited by 230 papers, by iCite.
Cite this record
ConductScience Library. Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis. Papers, record 55716. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/55716
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Autoimmune Diseases | Major topic |
| Cytotoxicity Tests, Immunologic | Major topic |
| Hepatitis | Major topic |
| Liver | Major topic |
| Adult | |
| Aged | |
| Autoantibodies | |
| B-Lymphocytes | |
| Chronic Disease | |
| Culture Techniques | |
| Female | |
| Humans | |
| Lipoproteins | |
| Liver Function Tests | |
| Male | |
| Middle Aged | |
| T-Lymphocytes |
Source PubMed
Cited by89
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 230 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41014384 | Piceatannol improves autoimmune hepatitis by inhibiting the immune activities of T cells and macrophages through binding with c-Jun. | Immunol Res | 2025 | https://conductscience.org/library/papers/41014384 | PubMed |
| 39117005 | B and T cells: (Still) the dominant orchestrators in autoimmune hepatitis. | Autoimmun Rev | 2024 | https://conductscience.org/library/papers/39117005 | PubMed |
| 38404291 | The significance of gut microbiota in the etiology of autoimmune hepatitis: a narrative review. | Front Cell Infect Microbiol | 2024 | https://conductscience.org/library/papers/38404291 | PubMed |
| 35100095 | Pathogenicity and virulence of Hepatitis B virus. | Virulence | 2022 | https://conductscience.org/library/papers/35100095 | PubMed |
| 34650567 | Dysfunctional Immune Regulation in Autoimmune Hepatitis: From Pathogenesis to Novel Therapies. | Front Immunol | 2021 | https://conductscience.org/library/papers/34650567 | PubMed |
| 33652348 | Regulatory T cells in autoimmune hepatitis: an updated overview. | J Autoimmun | 2021 | https://conductscience.org/library/papers/33652348 | PubMed |
| 30599169 | Immunogenicity of Protein Pharmaceuticals. | J Pharm Sci | 2019 | https://conductscience.org/library/papers/30599169 | PubMed |
| 28512353 | Favorable Response to Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients with High Serum Fucosyl-Agalactosyl IgG. | Sci Rep | 2017 | https://conductscience.org/library/papers/28512353 | PubMed |
| 26000135 | Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity. | Auto Immun Highlights | 2012 | https://conductscience.org/library/papers/26000135 | PubMed |
| 19452572 | Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment. | World J Gastroenterol | 2009 | https://conductscience.org/library/papers/19452572 | PubMed |
| 9951951 | Drug therapy in the management of type 1 autoimmune hepatitis. | Drugs | 1999 | https://conductscience.org/library/papers/9951951 | PubMed |
| 7851212 | Autoimmune hepatitis. Evolving concepts and treatment strategies. | Dig Dis Sci | 1995 | https://conductscience.org/library/papers/7851212 | PubMed |
| 7450561 | Autoantibodies against liver-specific membrane lipoprotein in acute and chronic liver diseases: studies on organ-, species-, and disease-specificity. | Gut | 1980 | https://conductscience.org/library/papers/7450561 | PubMed |
| 7436533 | Immune responses to liver membrane antigens in patients with cystic fibrosis and liver disease. | Arch Dis Child | 1980 | https://conductscience.org/library/papers/7436533 | PubMed |
| 7379331 | Cell-mediated immunity to liver antigen in toxic liver injury. I. Occurrence and specificity. | Clin Exp Immunol | 1980 | https://conductscience.org/library/papers/7379331 | PubMed |
| 7318258 | Natural killer activity in patients with biopsy-proven liver disease. | Clin Exp Immunol | 1981 | https://conductscience.org/library/papers/7318258 | PubMed |
| 7307345 | Histological and immunological investigation of liver-specific protein (LSP) immunized rabbits compared with patients with liver disease. | Clin Exp Immunol | 1981 | https://conductscience.org/library/papers/7307345 | PubMed |
| 7286562 | Antibody dependent cellular cytotoxicity in chronic active liver diseases. | Gastroenterol Jpn | 1981 | https://conductscience.org/library/papers/7286562 | PubMed |
| 7251131 | Influence of (+)-cyanidanol-3 on the leukocyte migration inhibition test carried out in the presence of purified protein derivative and hepatitis B surface antigen. | Infect Immun | 1981 | https://conductscience.org/library/papers/7251131 | PubMed |
| 7227762 | Pathological study of chronic D-galactosamine induced hepatitis in mice by administration of adjuvants - an animal model of the chronic active hepatitis. | Gastroenterol Jpn | 1981 | https://conductscience.org/library/papers/7227762 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/55716
GET https://conductscience.org/api/papers/v1/55716/cited_by?page=2